Fundraising for treatment

Rio is a happy, playful and energetic three-year-old who adores cars and spending time with his big sister Lillyrose! In August 2023, Rio was diagnosed with stage 4 high-risk neuroblastoma.

Leonardo is a five-year-old from London who loves superheroes and motorcycles. In May 2022, Leonardo was diagnosed with high-risk neuroblastoma and he completed frontline treatment in July 2023 but sadly his disease progressed.

Four-year-old Archie loves Hot Wheels and Paw Patrol. In July 2022, Archie was diagnosed with high-risk neuroblastoma. His family are fundraising £154,000 so he can enrol on the DFMO study in Charlotte once he finishes his frontline treatment in October. This trial is currently not available on the NHS.

Teddy is a four-year-old from West Sussex who is obsessed with trains! In July 2022, Teddy was diagnosed with high-risk neuroblastoma. Thanks to your incredible support, in February 2024 Teddy enrolled on the DFMO Study at the Penn State Children's Hospital.

Flora is an energetic, outdoor-loving five-year-old from East Lothian, Scotland. Her family are continuing to fundraise after Flora sadly relapsed in September 2023 and her total now reflects the new campaign fund total.

Arianna is a beautiful, funny and kind-hearted eight-year-old, who loves dressing up! In November 2021, she was diagnosed with high-risk neuroblastoma. Arianna is currently enrolled on the bivalent vaccine clinical trial in New York, thanks to an incredible community of support for her campaign.

Jessica is the sweetest, kindest four-year-old who loves animals, all things Peppa Pig and playing with her cousin, Maeve. Jessica has high-risk neuroblastoma.

Dulcie is a beautiful and brave seven-year-old from Shropshire. She loves My Little Pony, all Disney princesses, rainbows and everything that sparkles! Dulcie was diagnosed with high-risk neuroblastoma in December 2021.

Kayla is a very happy and lively six-year-old from Norwich. She loves Minnie Mouse, Frozen, Peppa Pig and all things pink! Kayla was diagnosed with high-risk neuroblastoma and in November 2022, her end-of-treatment scans showed disease progression.

Eden is full of life, very cheeky and loved by so many people. Eden is currently enrolled on the bivalent vaccine clinical trial in New York, thanks to an incredible community of support for Eden’s campaign.

Katie Rose is a fun-loving, quick-witted, brave 13-year-old girl, who loves making slime, playing Fortnite on her PlayStation, Roblox and Toca Life World and jumping on her trampoline. In March 2018, Katie Rose was diagnosed with high-risk neuroblastoma.

Kira’s 20 years old and has been fighting neuroblastoma since she was 11. She’s faced years of gruelling treatment to try to get rid of her disease and has relapsed eight times.

Maysaa is six years old and loves strawberries, unicorns and rainbows. Maysaa enrolled on the DFMO study in Charlotte in August 2022 to continue her treatment, which was made possible by the community of supporters who helped raise the £106,000 needed.

13-year-old Peter is a keen gamer and loves all things Lego and playing Minecraft. Since January 2022, he has been enrolled on the DFMO study in Charlotte, made possible thanks to an incredible community of support for his campaign.

Eight-year-old Poppy loves playing in the park with her friends and her brother. Poppy completed her frontline treatment in October 2022 and scans continue to show no evidence of active disease.

Ashlee is 17 years old and loves music, fashion and her dog, Angel. Ashlee completed the bivalent vaccine clinical trial in December 2021, thanks to the amazing support her campaign received to raise the £239,000 needed.

Oliver is described by his dad as the ‘happiest, most fun-loving boy you can imagine – a real joy to be around’. Oliver enrolled on the bivalent vaccine clinical trial in New York in February 2019.

Maya is 10 years old. She’s the same feisty and stubborn girl her family have known since she was born. After completing frontline treatment for high-risk neuroblastoma in 2020 and the bivalent vaccine clinical trial in America, Maya sadly relapsed in the summer of 2023.